Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,98 USD | -1,00% | -13,54% | -86,55% |
11/04 | AMYLYX PHARMACEUTICALS, INC. : Baird is Neutraal gestemd over aandeel | ZM |
10/04 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
Omzet 2024 * | 102 mln. 95,36 mln. | Omzet 2025 * | 167K 156K | Marktkapitalisatie | 134 mln. 126 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -105 mln. -98,38 mln. | Nettowinst (verlies) 2025 * | -84 mln. -78,7 mln. | EV/omzet 2024 * | 0,81 x |
Nettoliquiditeiten 2024 * | 51,6 mln. 48,35 mln. | Nettoliquiditeiten 2025 * | 168 mln. 158 mln. | EV/omzet 2025 * | -205 x |
K/w-verhouding 2024 * |
-1,29
x | K/w-verhouding 2025 * |
-1,67
x | Werknemers | 384 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83% |
Recentste transcriptie over Amylyx Pharmaceuticals, Inc.
1 dag | -1,00% | ||
1 week | -13,54% | ||
Lopende maand | -30,28% | ||
1 maand | -30,77% | ||
3 maanden | -86,69% | ||
6 maanden | -88,37% | ||
Lopend jaar | -86,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 01-01-13 |
Josh Cohen
FOU | Founder | 33 | 01-01-13 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 01-01-15 |
Kari Firestone
BRD | Director/Board Member | - | 16-03-23 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 29-03-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.14% | 0 M€ | 0,00% | - | |
0.09% | 237 M€ | -1,30% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +4,47% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,98 | -1,00% | 1 034 036 |
17-04-24 | 2 | -0,50% | 1 734 078 |
16-04-24 | 2,01 | -2,90% | 2 157 902 |
15-04-24 | 2,07 | -1,43% | 3 707 247 |
12-04-24 | 2,1 | -8,30% | 2 824 749 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-86,55% | 134 mln. | |
-5,99% | 84,46 mld. | |
+3,95% | 40,85 mld. | |
-26,37% | 27,69 mld. | |
+52,66% | 24,28 mld. | |
-6,59% | 17,09 mld. | |
-32,37% | 13,67 mld. | |
-15,88% | 11,86 mld. | |
-10,45% | 11,79 mld. | |
-2,70% | 8,07 mld. |